glp-1 agonist online learning resources Navigating use in therapy Healthy GLP-1 Journey Course
Description
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes
This study included 41 participants (RYGB: n=21, OAGB: n=20) from the randomized RYSA trial with similar amounts of bypassed intestine between the procedures
Do not reuse
Williams emphasi
See real GLP-1 before and after results week by week
